US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Voluntary Benefits Suits Emerge As New ERISA Battleground No Photo Available

Kellie Mejdrich

A recent crop of proposed class actions targeting employers' insurance-related voluntary benefits offerings — for things like critical... (more story)

J&J $5.5B Talc MDL Deal, $25.4M Cooley Judgment And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at Johnson & Johnson's $5.5 billion commitment in a proposed settlement to resolve thousands of suit... (more story)

This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca No Photo Available

Yeji Jesse Lee

Healthcare providers and drugmakers posted results for the second quarter of 2026 this past week, giving investors a closer look at ho... (more story)